Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period

American Journal of Cardiology

Volumn 80, Issue 9 B, 1997, Pages

  Hjalmarson, Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PROPRANOLOL; SOTALOL; TIMOLOL;

ACUTE HEART INFARCTION; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SOLUBILITY; FOLLOW UP; HEART DEATH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIPOPHILICITY; MORTALITY; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0030699497     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00837-0     Document Type: Conference Paper

References (29)

1. Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute (Volume 2). DHEW, NIH publication No. 82-2035, Washington DC: US Government Printing Office; 1981:114-122.
2. Yusuf S, Wittes J, Friedman L. Overview of randomized clinical trials in heart disease, I treatments following myocardial infarction . JAMA. 260:1988;2088-2093.
3. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 304:1981;801-807.
4. A randomized trial of propranolol in patients with acute myocardial infarction, I mortality results . JAMA. 247:1982;1407-1414.
5. Hjalmarson Å, Elmfeldt D, Herlitz J, Holmberg S, Málek I, Nyberg G, Rydén L, Swedberg K, Vedin A, Waagstein F, Waldenström A, Waldenström J, Wedel H, Wilhelmsen L, Wilhelmsson C. Effect on mortality of metoprolol in acute myocardial infarction a double-blind randomised trial . Lancet. ii:1981;823-827.
6. Metoprolol in Acute Myocardial Infarction (MIAMI) a randomised placebo-controlled international trial . Eur Heart J. 6:1985;199-226.
7. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction ISIS-1 . Lancet. ii:1986;57-66.
8. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction an overview of the randomized trials . Prog Cardiovasc Dis. 27:1985;335-371.
9. Olsson G, Wikstrand J, Warnold I, Manger Cats V, McBoyle D, Herlitz J, Hjalmarson Å, Sonnenblick EH. Metoprolol-induced reduction in postinfarction mortality pooled results from five double-blind randomised trials . Eur Heart J. 13:1992;28-32.
10. Julian DG, Prescott RJ, Jackson FS, Szekely P. Controlled trial of sotalol for one year after myocardial infarction. Lancet. i:1982;1142-1147.
11. Rydén L, Arineigo R, Arnman K, Herlitz J, Hjalmarson Å, Holmberg S, Reyes C, Smedgård P, Swedberg K, Vedin A, Waagstein F, Waldenström A, Wilhelmsson C, Wedel H, Yamamoto M. A double-blind trial of metoprolol in acute myocardial infarction effects on ventricular tachyarrhythmias . N Engl J Med. 308:1983;614-618.
12. Norris RM, Barnaby PF, Brown MA, Geary GG, Clarke ED, Logan RL, Sharpe DN. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. ii:1984;883-886.
13. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
14. Parker GW, Michael LH, Hartley CJ, Skinner JE, Entman ML. Central beta-adrenergic mechanisms may modulate ischemic ventricular fibrillation in pigs. Circ Res. 66:1990;259-270.
15. Åblad B, Bjurö T, Björkman J-A, Edström T, Olsson G. Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone (Abstr.) . J Am Coll Cardiol. 17:(suppl):1991;165.
16. Åblad B, Brax O, Ewaldsson L, Lundberg JM. Metoprolol reduces stress induced neuropeptide Y (NPY) release in pigs (Abstr.) . Circulation. 90:(No. 4 pt 2):1994;I-268.
17. Chadda K, Goldstein S, Byington R. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation. 73:1986;503-510.
18. Hjalmarson Å. Empiric therapy with beta-blockers. PACE. 17:(No. 3 pt 2):1994;460-466.
19. Herlitz J, Hjalmarson Å, Waagstein F. Effect of metoprolol among patients with suspected acute myocardial infarction and signs of congestive heart failure (Abstr.) . Circulation. 94:(suppl I):1996;I-665.
20. Kjekshus J, Gilpin E, Gali G, Blackey AR, Henning H, Ross J. Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J. 11:1990;43-50.
21. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. ii:1988;349-360.
22. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the Survival and Ventricular Enlargement trial . N Engl J Med. 327:1992;669-677.
23. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-823.
24. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) . N Engl J Med. 327:1992;678-684.
25. Yusuf S, Furberg CD. Effects of calcium channel blockers on survival after acute myocardial infarction. Cardiovasc Drugs Ther. 1:1987;343-344.
26. ISIS-4 a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction . Lancet. 345:1995;669-685.
27. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial . N Engl J Med. 320:1989;618-627.
28. Risenfors M, Herlitz J, Bergh C-H, Dellborg M, Gustavsson G, Gottfridsson C, Lomsky M, Swedberg K, Hjalmarson Å. Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction results from the TEAHAT Study . J Intern Med. 229:(suppl 734):1991;35-42.
29. Boissel J-P, Leizorovicz A, Picolet H, Ducret T. Efficacy of acebutolol after acute myocardial infarction (the APSI trial). Am J Cardiol. 66:(suppl):1990;24C-31C.